To ask the Secretary of State for Health and Social Care, how many participants were recruited into NIHR supported phase 3 trials for (a) dementia, (b) cancer, (c) stroke and (d) coronary heart disease over the last 10 years.
Answered on
28 March 2022
The following table shows the number of participants recruited into phase three trials in England supported by the National Institute for Health Research since 1 April 2012.
Dementia | 11,227 |
Cancer | 107,569 |
Stroke | 27,577 |
Coronary heart disease* | 20,549 |
Note:
*Includes studies on atherothrombosis and prevention of coronary artery disease.
Answered by
Department of Health and Social Care